Updated January 3, 2011:
Vyvanse was officially launched in Canada on February 1, 2010.
When it was first launched – it was only officially approved for use in children – aged 6-12 years old. As of November 2010, Vyvanse is now officially indicated for use in ADHD in children (6-12 years old), teenagers (13-18 years old), and adults (18-65 years old). This means that Vyvanse is now officially indicated in Canada for use in ADHD ‘across the lifespan’ – i.e. from childhood to adulthood.
Dosage of Vyvanse in Canada:
Vyvanse is available in these dosage strengths in Canada: 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg.
In the US, there is also a 70 mg capsule – but Health Canada wasn’t convinced that it was needed – so for now, the highest dose capsule that we have in Canada is the 60 mg.
Doctors will generally start with a lower dose (often 30 mg) and then increase to a higher dose (often 50 mg). Of course, your doctor will tailor the treatment to your needs.
Vyvanse is a the first prodrug for ADHD. This means that the medication is inactive until an enzyme in the body works to activate it. To read more about how it works, visit this blog post on Vyvanse.
To read the press release on Vyvanse being released in Canada, please view it here.
This blog has several articles on Vyvanse, but my favorite is the one where my readers have shared their experiences with Vyvanse (over 800 comments at this time) about whether Vyvanse works.
You can find more articles by looking at the ‘related posts’ below this article.
Please share any comments or issues with Vyvanse being in Canada below.